Ryou Fujii
About
In The Last Decade
Ryou Fujii
19 papers receiving 379 citations
Peers
Comparison fields: 5 of 54
- Radiology, Nuclear Medicine and Imaging 303
- Molecular Biology 65
- Materials Chemistry 65
- Radiation 64
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Ryou Fujii
This map shows the geographic impact of Ryou Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryou Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryou Fujii more than expected).
Fields of papers citing papers by Ryou Fujii
This network shows the impact of papers produced by Ryou Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryou Fujii. The network helps show where Ryou Fujii may publish in the future.
Co-authorship network of co-authors of Ryou Fujii
This figure shows the co-authorship network connecting the top 25 collaborators of Ryou Fujii. A scholar is included among the top collaborators of Ryou Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryou Fujii. Ryou Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | Visualization of myocardial phosphoinositide turnover with 1-[1-(11)C]-butyryl-2-palmitoyl-rac-glycerol in rats with myocardial infarction. | 6 |
| 5 | Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. | 35 |
| 6 | 9 | |
| 7 | 28 | |
| 8 | Neural features of recovery from CNS injury revealed by PET in human brain. | 7 |
| 9 | 3 | |
| 10 | Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. | 113 |
| 11 | Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. | 137 |
| 12 | 2 | |
| 13 | Protein kinase C imaging using carbon-11-labeled phorbol esters: 12-deoxyphorbol 13-isobutyrate-20-[1-11C]butyrate as the potential ligand for positron emission tomography. | 4 |
| 14 | Phosphoinositide turnover imaging linked to muscarinic cholinergic receptor in the central nervous system by positron emission tomography. | 10 |
| 15 | 13 | |
| 16 | Membrane trapping of carbon-11-labeled 1,2-diacylglycerols as a basic concept for assessing phosphatidylinositol turnover in neurotransmission process. | 15 |
| 17 | No-carrier-added carbon-11-labeled sn-1,2- and sn-1,3-diacylglycerols by [11C]propyl ketene method. | 5 |
| 18 | 2 | |
| 19 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.